{"id":"https://openalex.org/W4397046520","doi":"https://doi.org/10.1681/asn.20223311s1381a","title":"Immunotherapy-Induced Glomerulonephritis: Whodunit?","display_name":"Immunotherapy-Induced Glomerulonephritis: Whodunit?","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4397046520","doi":"https://doi.org/10.1681/asn.20223311s1381a"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20223311s1381a","doi":"https://doi.org/10.1681/asn.20223311s1381a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20223311s1381a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066643860","display_name":"Brian Joseph Benes","orcid":"https://orcid.org/0009-0008-4607-3981","observed_orcids":["https://orcid.org/0009-0008-4607-3981"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Benes","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080927936","display_name":"Kate-Lynn E. Muir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate-Lynn Muir","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051001649","display_name":"Kirk W. Foster","orcid":"https://orcid.org/0000-0003-0616-2679","observed_orcids":["https://orcid.org/0000-0003-0616-2679"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirk W. Foster","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072808304","display_name":"Alissa Marr","orcid":"https://orcid.org/0000-0002-2545-3570","observed_orcids":["https://orcid.org/0000-0002-2545-3570"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alissa S. Marr","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008521002","display_name":"Ketki K. Tendulkar","orcid":"https://orcid.org/0000-0001-8988-564X","observed_orcids":["https://orcid.org/0000-0001-8988-564X"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ketki K. Tendulkar","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I59130452"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"11S","first_page":"381","last_page":"381"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.826200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.826200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.14059999585151672,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.7509999871253967},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/glomerulonephritis","display_name":"glomerulonephritis","score":0.9010000228881836},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.871999979019165},{"id":"https://openalex.org/keywords/talimogene-laherparepvec","display_name":"talimogene laherparepvec","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oncolytic-virotherapy","display_name":"oncolytic virotherapy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7950000166893005},{"id":"https://openalex.org/keywords/acute-interstitial-nephritis","display_name":"acute interstitial nephritis","score":0.9070000052452087},{"id":"https://openalex.org/keywords/c3-glomerulopathy","display_name":"C3 glomerulopathy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.7120000123977661},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7020000219345093},{"id":"https://openalex.org/keywords/mesangial-deposits","display_name":"mesangial deposits","score":0.6240000128746033},{"id":"https://openalex.org/keywords/kidney-biopsy","display_name":"renal biopsy","score":0.39500001072883606},{"id":"https://openalex.org/keywords/immunotherapy-side-effects","display_name":"immunotherapy side effects","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2780368995","wikidata":"https://www.wikidata.org/wiki/Q605006","display_name":"Glomerulonephritis","level":3,"score":0.7088295817375183},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6335521936416626},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5538356900215149},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40663692355155945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.246263325214386},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.17537403106689453},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.12691181898117065}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20223311s1381a","doi":"https://doi.org/10.1681/asn.20223311s1381a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20223311s1381a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2550815089","https://openalex.org/W2736263260","https://openalex.org/W3007633138","https://openalex.org/W3175214421","https://openalex.org/W4397041440","https://openalex.org/W2951027848","https://openalex.org/W2979299948","https://openalex.org/W3144311337","https://openalex.org/W3169626257","https://openalex.org/W4400973339"],"abstract_inverted_index":{"Introduction:":[0],"Kidney":[1,136],"immune-related":[2],"adverse":[3,24,252,295,356],"events":[4,25,296],"are":[5,297],"well":[6],"recognized":[7],"side":[8],"effects":[9],"of":[10,20,39,72,232,240,278,280,304,310,354],"immune":[11,22,243,293,319,355],"checkpoint":[12],"inhibitor":[13],"therapy.":[14,29,281],"We":[15],"present":[16],"a":[17,129,259,351],"unique":[18],"case":[19,302],"evolving":[21],"related":[23],"with":[26,46,61,128,181,204,255,268,307,316,321],"ongoing":[27],"melanoma":[28,176,291],"Case":[30],"Description:":[31],"A":[32,69],"72-year-old":[33],"man":[34],"was":[35,76,82,86,107,147,172,179],"referred":[36],"for":[37,49,113,149,186,194],"evaluation":[38],"acute":[40,73,219],"kidney":[41,332],"injury":[42,272,333],"after":[43,227,234],"being":[44],"treated":[45,180],"adjuvant":[47],"nivolumab":[48,229,335],"malignant":[50],"melanoma.":[51,115],"Serum":[52,161],"creatinine":[53,98,132,205],"increased":[54],"from":[55,334],"1.0":[56],"mg/dL":[57,60],"to":[58,100,133,175,202,217,345],"3.1":[59],"urine":[62],"protein/creatinine":[63],"ratio":[64],"0.3":[65],"mgTP/mgCR,":[66],"without":[67],"hematuria.":[68],"presumed":[70],"diagnosis":[71],"interstitial":[74],"nephritis":[75,221],"made":[77],"based":[78],"on":[79,88,109,325],"eosinophiluria.":[80],"Nivolumab":[81],"stopped":[83,173],"and":[84,93,123,140,151,166,223,230,292,323],"he":[85,106,120],"started":[87,108],"prednisone":[89],"60":[90],"mg":[91],"daily":[92,193],"lisinopril.":[94],"After":[95],"1":[96,183,191,211],"month,":[97],"improved":[99,198],"1.2":[101],"mg/dL.":[102,135],"Six":[103],"months":[104,117,201],"later":[105],"talimogene":[110],"laherparepvec":[111],"(T-VEC)":[112],"progressive":[114],"Four":[116],"into":[118],"treatment,":[119],"developed":[121],"edema":[122],"proteinuria":[124,233],"(UPCR-":[125],"10.5":[126],"mgTP/mgCR),":[127],"rise":[130],"in":[131,258,288],"1.8":[134],"biopsy":[137],"showed":[138],"mesangio-":[139],"focal":[141,317],"endocapillary":[142],"proliferative":[143],"glomerulonephritis.":[144],"Immunofluorescence":[145],"(IF)":[146],"positive":[148],"C3":[150,263],"trace":[152],"C1Q.":[153],"Electron":[154],"microscopy":[155],"had":[156,312],"electron":[157],"dense":[158],"mesangial":[159,318],"deposits.":[160],"complement":[162],"levels":[163],"were":[164,169],"normal":[165],"functional":[167],"complements":[168],"negative.":[170],"T-VEC":[171,235,241,282,347],"due":[174,344],"progression.":[177],"He":[178],"rituximab":[182],"g":[184,192],"weekly":[185],"4":[187,195],"weeks,":[188],"methylprednisolone":[189],"IV":[190],"days.":[196],"Proteinuria":[197],"over":[199],"6":[200],"0.4":[203],"1.4":[206],"mg/dl.":[207],"Discussion:":[208],"Programmed":[209],"death":[210],"inhibitors":[212],"(PD1i)":[213],"have":[214,327],"been":[215,266,328],"described":[216],"cause":[218,353],"tubulointerstitial":[220],"(ATIN)":[222],"glomerular":[224],"injury.":[225],"Improvement":[226],"stopping":[228],"onset":[231,331],"administration":[236],"raises":[237],"the":[238,248],"possibility":[239],"induced":[242],"mediated":[244,294],"effect.":[245],"ATIN":[246],"is":[247,283],"most":[249],"common":[250],"renal":[251,271],"event":[253],"associated":[254,306],"PD1i":[256],"(93%":[257],"recent":[260],"series).":[261],"Although,":[262],"glomerulopathy":[264],"has":[265],"reported":[267],"nivolumab.":[269],"Typically,":[270],"often":[273],"occurs":[274],"within":[275],"2-4":[276],"weeks":[277],"cessation":[279],"an":[284],"oncolytic":[285],"virus":[286],"used":[287],"unresectable":[289],"metastatic":[290],"less":[298],"common.":[299],"Two":[300],"other":[301],"reports":[303],"GN":[305,315],"T-VEC,":[308],"one":[309],"which":[311],"minimal":[313],"change":[314],"deposition":[320],"IgM":[322],"C1q":[324],"IF":[326],"reported.":[329],"Delayed":[330],"cannot":[336],"be":[337,343,349],"excluded":[338],"or":[339],"these":[340],"findings":[341],"could":[342],"T-VEC.":[346],"should":[348],"considered":[350],"possible":[352],"events.":[357]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2024-05-19T00:00:00"}